Title Image


Charalampos Babis Kalodimos

Jude Children’s Research Hospital, Memphis USA
Chair, Department of Structural Biology Joseph Simone Endowed Chair in Discovery Research
St. Jude Children’s Research Hospital


  • 6/2017- : Chair, Department of Structural Biology, St. Jude Children’s Research Hospital, Memphis, TN
  • 7/2015-5/2017: Distinguished Professor, University of Minnesota, Department of Biochemistry, Molecular Biology & Biophysics, Minneapolis, MN
  • 1/2004 – 6/2015: Assistant, Associate (1/2008) and Professor (7/2011), Rutgers University, Department of Chemistry & Chemical Biology, Piscataway, NJ


Postdoctoral Fellow, University of Utrecht, The Netherlands – 9/1999-11/2003. Supervisor: Robert Kaptein
Main research interests: Biomolecular NMR spectroscopy; Protein-DNA interactions; Protein dynamics
PhD thesis, University of Ioannina, Greece & Institut Curie, Paris, France — 1995-1999. Supervisors: Ioannis Gerothanassis & Michel Momenteau. Sponsored by: the Greek Scholarship Foundation, EMBO, FEBS and the French Embassy (awarded with Honors). Main research interests: Bioinorganic Chemistry; Hemoproteins; NMR Spectroscopy
Bachelor in Biochemistry, University of Ioannina, Greece — 1990-1994


  • Ritter Memorial Lecture, Miami University, 2023.
  • Fellow of the Biophysical Society, 2020.
  • Sir Rex Richards Lecture, Oxford University, 2020.
  • Joseph Simone Endowed Chair, 2017.
  • Henry A. Lardy Distinguished Lecture, 2017.
  • The Raymond and Beverly Sackler International Prize in the Physical Sciences, 2016.
  • Stig Sunner Young Investigator Award, 2013.
  • Biophysical Society Michael and Kate Bárány Young Investigator Award, 2011.
  • New York Academy of Sciences Blavatnik Young Investigator Award, 2011.
  • Protein Society Young Investigator Award, 2010.
  • Johnson & Johnson Discovery Award, 2004.
  • Bijvoet Center for Biomolecular Research (University of Wisconsin-Madison, USA) 2002.
  • Eminent Scientist Nomination (by the Greek Ministry of Defense) 2001.
  • EMBO Fellowship (University of London, U.K.) 1998.
  • FEBS Fellowship (University Paris 7, France) 1998.
  • French Embassy in Greece (Institute Curie, Paris, France) 1997.
  • FEBS Fellowship (Institute Curie, Paris, France) 1996.
  • Erasmus- ECTS (University Paris XI, France) 1994-1995.
  • 4-year PhD Fellowship from the Greek Scholarship Foundation (ranked 1st) 1995.

Ioannis P. Nezis

University of Warwick, UK

  • 2020 – : Professor of Cell Biology, School of Life Sciences, University of Warwick, UK
  • 2018 – 2020: Reader in Cell Biology, School of Life Sciences, University of Warwick, UK
  • 2012 – 2017: Associate Professor of Cell Biology, School of Life Sciences, University of Warwick, UK
  • 2009-2012: Assistant Professor of Cell Biology, Department of Biological Applications & Technology, University of Ioannina, Greece
  • 2007-2009: Post-doctoral research fellow in Department of Biochemistry, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway
  • 2005-2007: Post-doctoral research fellow in Department of Cell Biology and Biophysics, Faculty of Biology, University of Athens, Greece
  • 2004-2005: Post-doctoral research fellow in Institute of Biological Research and Biotechnology, National Hellenic Research Foundation, Athens, Greece
  • 2002-2004: National military service, Greece
  • 1998-2002: PhD Thesis, Cell Biology, Department of Cell Biology and Biophysics, Faculty of Biology, University of Athens, Greece
  • 1993-1997: BSc, Biology, Faculty of Biology, University of Athens, Greece

Research: Technical Summary
In my group we are interested in the role of autophagy in health and disease. Autophagy is an evolutionarily conserved catabolic process that involves the degradation of cytoplasmic material through the lysosomal pathway. Autophagy is a cellular response in nutrient starvation but it is also responsible for the removal of aggregated proteins, damaged organelles and developmental remodeling. Recent studies have shown that dysfunction in autophagy has been implicated in an increasing number of diseases from bacterial and viral infections to cancer and more recently in neurodegeneration and other ageing-related diseases.

Interestingly, it has been shown that induction of autophagy can increase longevity in multiple animal species. Sequestration and degradation of cytoplasmic material by autophagy can be selective through receptor and adaptor proteins. It is therefore important to identify the proteins required for recognition and targeting of the various autophagic cargo for degradation and to elucidate the role of selective autophagy in normal and pathological conditions, especially at the organismal level. We are using mammalian cells in vitro and the fruit fly Drosophila melanogaster, as a genetically modifiable model organism to investigate the mechanisms of autophagy in the context of the physiology of the cell, the system and the living organism. We have developed several molecular markers for monitoring autophagy in vivo.

The major aims of our research are:

  • To identify novel selective autophagy receptors and adaptors
  • To understand the cellular and molecular mechanisms of autophagy during ageing
  • To elucidate the cellular and molecular mechanisms of autophagy in diseases such as neurodegeneration, obesity, bacterial and viral infections and tumorigenesis

The long term goal of our research is to develop therapeutic strategies for these diseases.
We are studying the function of autophagy genes using a combination of RNAi mediated knock down, targeted gene expression, conditional knock out and we use a wide range of approaches, including confocal microscopy, conventional electron microscopy, immuno-gold electron microscopy, biochemical methods and bioinformatics.


Annalisa Pastore

ESRF (European Synchrotron Radiation Facility), France
Structural biology, Biophysical techniques, NMR structure determination of proteins,
Molecular Biology and Biochemistry, Structural and functional genomics, Bioinformatics and Computational methods

Bibliometric data:
Total Number of papers: 270 research papers and 50 reviews or commentaries. Total Number of Citations 16272, h index 73, i10-index 227 according to Google Scholar. Citations since 2015, h index 35, Number of citation 5311, i10-index 129


  • 1983 – 1986 PhD in Chemistry (Dottorato di Ricerca) Laboratory of Spectroscopy, University of Naples, Italy.
  • May 1981 Master with honour, 110/110 cum laude. (Laurea in Chemistry), University of Naples, Italy.
  • 1975 – 1981 Studies in Chemistry, University of Naples, Italy


  • 2022-present Scientific Director for Chemistry and Life Science
  • 2013-2021 Full Professor, King’s College London (full time Oct2013-Apr2015 and Apr2019 to now, part time 2015-2019)
  • Oct2018-Apr2019 Full professor Scuola Normale di Pisa
  • 2015-2018 Full Professor, University Pavia (part time)
  • 1997 – 2013 Team Leader, MRC NIMR, Mill Hill, London
  • 1991 – 1997 Group leader at EMBL Heidelberg, Germany, in the Structures Program’
  • 1988 – 1991 Staff scientist position at EMBL Heidelberg, Germany, in the Biocomputing Program.
  • 1986 – 1987 Postdoctoral fellow at the Department of Biochemistry, University of Oxford, UK


  • 2015 Honorary Fellow of the Technical University of Munich
  • Oct 2013 Elected Member of the Academia Europaea
  • Oct 2003 Honorary professor of London University
  • Oct 2001 Elected EMBO Member

Patents and other translational work:
Non-anaphylactic forms of grass pollen Ph1 p6 allergen and their use. (00975093.6-2405-SE0002062)
Solved the structure of a domain of a Meningitis protein which is part of the Novartis vaccine for Meningitis B

Irit Sagi

Vice President, Innovation and Technology Transfer
Department of Immunology & Regenerative Biology
The Weizmann Institute of Science, Israel

Born in Israel, Prof. Irit Sagi received a BSc in Physical Chemistry from American University (1988) and a PhD degree in biophysics/bioinorganics from Georgetown University (1992), both in Washington DC. She returned to the Weizmann Institute to perform postdoctoral research in the group of Prof. Ada Yonath, laureate of the 2009 Nobel Prize in Chemistry. Prof. Sagi continued her postdoctoral studies at the Max Planck Institute in Berlin and joined the faculty of Chemistry at the Weizmann Institute in 1998. In 2005-2006, she spent a sabbatical as a visiting professor at Harvard University and Novartis Research Institutes for BioMedical Research in Boston. She served as Dean of the Feinberg Graduate School at the Weizmann Institute from 2014-2019, when she assumed the position of Vice President for Innovation and Technology Transfer and Chair of the Board of Directors of Yeda , the Institute’s commercialization arm. She is the incumbent of the Maurizio Pontecorvo Professorial Chair.

Prof. Sagi develops and applies unique, multidisciplinary, and biophysical approaches to investigate the molecular processes of tissue and extracellular remodeling. Merging real-time spectroscopic and molecular imaging approaches, she was the first to reveal the complex dynamic molecular nature of extracellular remodeling enzymes, including matrix metalloproteinases and lysyl oxidases (MMPs and LOX). These are a group of human enzymes linked to developmental biology, cancer, inflammation, fibrosis, and infectious diseases. Insights derived from these studies led her to design a new class of inhibitory antibodies that thwart the enzymes’ negative action. These prototype antibodies and biological inhibitors are currently being developed for clinical use for human inflammatory and cancer diseases.
Prof. Sagi continues to focus her research efforts on novel integrated experimental tools tailored to decipher the extracellular matrix molecular remodeling code and molecular landscapes in healthy and diseased tissues. Specifically, she is using her biological inhibitors as molecular probes together with various omics to unravel new cellular and molecular pathways at the single-cell as well as at tissue levels. Recently, she demonstrated a novel use for proteases in promoting and increasing the rate of embryo implantation in mammals. This discovery led to her establishment of a a company, NanoCell, which is developing this technology in livestock and humans.

Prof. Sagi has more than 150 publications in peer-reviewed scientific journals and is the editor of two books. She received the Israel Chemical Society ADAMA prize in 2021, the Landau Prize of Mifal Hapais for Biochemistry in 2017, and the Juludan Prize for outstanding research projects in exact sciences and advanced medicinal technologies, in 2013. In 2006, she was named Inventor of the Year by Yeda Ltd. In 2003, she was awarded the Weizmann Institute Scientific Council Prize for Chemistry, and in 2000 she received the Jakubskind-Cymerman Research Prize. From 2009-2014 she served as the president of the Israel Biophysical Society and she is currently the president of the Israel Matrix Biology Society. Prof. Sagi is a member of the International Board of Directors of Future Fund for promoting Israel-Germany relations, and a member of the UK Israel Science Council.

Athanasios Typas

European Molecular Biology Laboratory, Germany
Group Leader & Senior Scientist, Co-Chair of Microbial Ecosystems & Infection Biology Transversal Themes,
European Molecular Biology Laboratory, Heidelberg

Nassos is a trained biochemist, geneticist, and systems biologist. He did his undergraduate studies in Chemistry/Biochemistry at the Aristotle University of Thessaloniki, PhD at the Free University of Berlin with Regine Hengge and postdoctoral research at UCSF with Carol Gross. Since 2011 he has been running his own group at the EMBL Heidelberg, and since 2020 he is a Senior Scientist. His group develops systems-based quantitative approaches and combines it with mechanistic work to study how bacteria interact with the environment, the host and with each other. The overarching goal is to identify new principles and mechanisms that govern such interfaces, and to shed light into the vast dark matter encoded in bacterial genomes. Key focal areas of the lab are on antibiotics, host-pathogen interactions and the human gut microbiome. Nassos has received a number of awards (e.g. NIH Pathway to Independence Award (K99/R00), Sofja Kovalevskaja Award from the Humboldt Foundation, ERC Consolidator Grant, VAAM Research Award) and is a member of the European Academy of Microbiologists and of EMBO.

Dimitrios Zevgolis

University College Dublin, Ireland

Dimitrios I. Zeugolis is Full Professor at the School of Mechanical & Materials Engineering, Principal Investigator at the Charles Institute of Dermatology, Senior Fellow at Conway Institute of Biomolecular & Biomedical Research and the Director of the Regenerative, Modular & Developmental Engineering Laboratory (REMODEL), all at the University College Dublin (UCD), Dublin, Ireland.

Dimitrios is Fellow of International Orthopaedic Research (FIOR) of the International Combined Orthopaedic Research Societies (ICORS) College of Fellows; Irish Ambassador of the European Orthopaedic Research Society (EORS); member of the Endorsement Committee of the Tissue Engineering & Regenerative Medicine International Society (TERMIS); and founder and council member of the Matrix Biology Ireland (MBI).

Dimitrios is Editor-in-Chief of Biomaterials and Biosystems (Elsevier), is editorial board member of >10 journals and acts as reviewer for >130 journals. He is Pool of Expert Board member and Core Committee member of the Biotechnology and Biological Sciences Research Council (BBSRC), UK; Review College member of Research Foundation Flanders (FWO); and serves as reviewer for >30 funding agencies.

Dimitrios has authored >100 peer-reviewed articles, >400 peer-reviewed conference papers and >15 peer-reviewed book chapters. He has chaired / co-chaired >15 conferences and >50 symposia and has acted as advisor in >25 conferences.

Dimitrios has secured 2 patents and founded 2 companies. He has conducted research for >40 companies and has been involved in the development and commercialisation of numerous food and medical device products.

Vassilis Aidinis

Biomedical Sciences Research Center “Alexander Fleming” Athens, Greece

Dr. Vassilis Aidinis received his B.Sc. in Biology from the University of Patras and his PhD in Molecular Biology from the University of Athens. He received his PhD training at the National Hellenic Research Foundation, where his work focused on the isolation and characterization of a novel heterogeneous nuclear RNP. At the same time and in collaboration with the Medical School of the University of Athens, he investigated various aspects of the involvement of snRNPs in autoimmunity. During his post-doctoral appointment at the D.H.R.R. Cancer Center of Mount Sinai’s School of Medicine, Howard Hughes Medical Institute, New York, his work focused on the biochemistry of V(D)J recombination and the involvement of chromatin architectural factors at the initial stages of the reaction. During his second postdoctoral appointment at the Molecular Genetics Laboratory of Hellenic Pasteur Institute, he explored the role of the synovial fibroblast in the pathogenesis of Rheumatoid Arthritis where, among others, he introduced, in Greece, the study of differential gene expression analysis. In 2001 he was appointed as a researcher C’ (eq. assistant professor, tenure track) at the Institute of Immunology, BSRC Fleming, where he committed his research efforts in deciphering the pathogenetic mechanisms governing chronic inflammation disorders (such as rheumatoid arthritis and idiopathic pulmonary fibrosis), as well as in establishing and developing the technology of DNA microarrays and related computational tools.

In 2012 he was appointed as a researcher A’ (eq., full professor, tenure) at the Institute of Immunology, BSRC Fleming, where he continues his research endeavors, currently focusing on two pillars: 1) the molecular and genetic dissection of pathogenetic mechanisms in the development of pulmonary inflammation, fibrosis and cancer, 2) the investigation of the role of autotaxin and phospholipid signaling in chronic inflammation and cancer. Noteworthy, his work on autotaxin and pulmonary fibrosis provided the scientific proof of principle for ongoing clinical trials in IPF, while the therapeutic potential of pharmaceutically targeting ATX in chronic inflammatory diseases is actively followed resulting in several patent applications.

His work is getting published in well-respected peer-reviewed journals, is a regular lecturer in various Academic Institutions and acts as a reviewer in several scientific journals. So far, he has trained 9 (+5) PhD students, 16 (+4) MSc students and 9 (+1) BSc students. He is a co-founder of Biomedcode Hellas, a Fleming spin-off for preclinical evaluation studies and novel drug development. He has set up the expression profiling facility of Fleming and has created Fibromine, a database and mining tool for target discovery in fibrosis. Moreover, he supervised the creation of several websites and mouse databases, in the context of various international collaborations aiming to promote mouse database functionalities and interoperability. Current technological focus include MS/MS lipidomics and scRNAseq analysis.

Alex Galanis

Democritus University of Thrace, Greece

Alex Galanis is an Associate Professor of Molecular Biology at the Department of Molecular Biology and Genetics, Democritus University of Thrace. He received his PhD in Biochemistry & Genetics from the Department of Biochemistry & Genetics at the University of Newcastle, and performed his postdoctoral research training at the University of Manchester, at the National Hellenic Research Foundation in Athens, and at the Department of ΜΒG, DUTH. His research interests focus on intracellular signal transduction pathways, mechanisms of transcriptional regulation, as well as on probiotic microorganisms, elucidating their molecular and cellular mechanisms of action and evaluating their potential health-promoting properties. He is involved in a number of EU-co-funded research projects in the areas of molecular microbiology, biochemical nutrition, and cellular mechanisms of disease. He has published 68 articles in peer-reviewed journals (~3,000 citations, h-factor 27). He serves on the editorial board of several international scientific journals and acts as an evaluator and reviewer for national and international grant proposals.

Chrysostomi Gialeli

Lund University, Sweden

Dr Chrysostomi Gialeli graduated from the Department of Chemistry at the University of Patras (Greece) with a Master of Science and PhD in the field of cancer microenvironment and extracellular matrix (Research group of Biochemical Analysis and Matrix Pathobiology). She moved to Sweden and Lund University in 2015 for her postdoctoral studies, where she specialized further on cancer immunology-complement system, drug design, as well as diabetes and cardiovascular complications. Dr Gialeli is currently a senior researcher in Lund university at Department of Clinical Sciences, focusing on Cardiovascular Research and Translational Studies with a special interest on extracellular matrix.

Konstantinos Kambas

Hellenic Pasteur Institute Athens, Greece


  • 1997-2000 BSc in Cell and Molecular Biology. University of Essex. UK
  • 2000-2001 MRes in Biotechnology”. University of Essex. UK
  • 2005-2009 (degree February 2010), PhD theses “Study of inflammatory models with systemic manifestations – The role if inflammation in thrombogenicity in models of respiratory disorders”, Medical School, Democritus University of Thrace. Greece.


  • 2010-2017 Postdoctoral researcher in Laboratory of Molecular Hematology. Democritus University of Thrace. Greece
  • 2017-2018 Postdoctoral researcher in Department of Pathophysiology, Medical School, National and Kapodistrian University of Athens
  • 2018-today Researcher (level C), Laboratory of Molecular Genetics, Hellenic Pasteur Institute


Undergraduate courses:

  • 2012-2016: Clinical Immunology in Medical School, Democritus University of Thrace (9th semester).
  • 2015-2016: Internal Medicine in Medical School, Democritus University of Thrace (13th semester).

Postgraduate courses:

  • 2011-2016: Clinical Pharmacology, postgraduate course, “Inflammatory mechanisms as targets for the development of new therapeutic agents”.

Guest Lecturer

  • 2013 – “Hands-On Light Microscopy Workshop – Basic & Advanced Techniques”, University of Luxembourg. “NETs under the microscope”
  • 2013 – 7th Seminar of Pathophysiology: lymphomas, Democritus University of Thrace. “Neutrophils Extracellular Traps (NETs) redefine the role of neutrophils: models in autoimmunity, autoinflammation, infection and cancer.”
  • 2015 – 5th Summer school of Immunology, Greece. “NETs as a common mechanism in the pathophysiology of human disorders”
  • 2017 – “Hands-On Light Microscopy Workshop – Basic & Advanced Techniques”, University of Luxembourg. “NETs as a common pathogenic mechanism- the paradigm of inflammation in FMF”
  • 2017 – 6th Summer school of Immunology, Greece. “NETs as a common pathogenic mechanism- the paradigm of inflammation in FMF”

Organizational/Administrative work

  • Member of organizing committee of 4th Summer school of Immunology (2013)
  • Member of organizing committee of 5th Summer school of Immunology (2015)
  • Member of organizing committee of 6th Summer school of Immunology (2017)
    Scientific interests – innate immune system, inflammation, autophagy, thrombosis, neutrophils, NETs, autoimmunity/autoinflammation, myelodysplastic syndrome, immunomodulation in infections.

Publication metrics

Publications in peer review journals (SCI): 37
1st author: 13
Last author: 3
Citations: 6479
Η-Factor: 26
Abstracts in International conferences: 9
Abstracts in Greek conferences: 7

Dr. Kambas has participated in 3 research grants and 2 clinical protocols:

Evgenia Ntini

IMBB-FORTH, Crete Greece

Evgenia Ntini studied Biology at the National and Kapodistrian University of Athens and graduated with a PhD in Biology from the University of Göttingen (2009). She received her first postdoctoral research training at Aarhus University, Denmark, where she focused on characterizing non-coding RNA transcription from human gene promoters (Ntini et al., 2013). She then moved to Berlin with an Alexander-von-Humboldt fellowship (host Max-Planck institute for Molecular Genetics) to continue her postdoctoral work on long non-coding RNAs and RNA modifications in regulation of gene expression (Ntini et al., 2018; Louloupi, Ntini et al., 2018). In 2021, she started her lab at the Institute of Molecular Biology and Biotechnology (IMBB-FORTH) with research objectives in RNA biology and gene regulation. She employs both computational and wet-lab methods to unravel the function of RNA in mammalian cells.

Andreas Papapetropoulos

National and Kapodistrian University of Athens, Greece

Andreas Papapetropoulos holds a bachelor’s degree in Pharmacy and a PhD in Pharmacology. He is currently Professor of Pharmacology at the National and Kapodistrian University of Athens and Affiliated Investigator at the Biomedical Research Foundation of the Academy of Athens, Greece. He is a fellow of the British Pharmacological Society and the American Heart Association, President of the Federation of European Pharmacological Societies and a member of the Editorial Board of the Br J Pharmacol, J Pharmacol Exp Ther, Pharmacol. Res and Arterioscler Thromb Vasc Biol. His research focuses on the molecular mechanisms of drug action and the preclinical evaluation of drugs, with an emphasis on the regulation, physiological functions and contribution of gasotransmitter (NO, H2S)-regulated pathways to disease initiation and progression.

Michael Paroussis 

Assoc. Professor, Dpt. Of Philosophy Faculty of Human & Social Sciences
University of Patras, Greece

Prof. Dr. Michael Paroussis was born in Athens, Greece in 1958, and is Assoc. Professor for Philosophy, Theory and Epistemology of Law at the Department of Philosophy of the University of Patras since 2004 and Head of Department since 2014. Ass. Professor at the Law Faculty of the University of Freiburg 1992-1999. Postgraduate Scholar of the Deutsche Forschungsgemeinschaft 2000-2003. PhD in Law at the University of Freiburg 1992, awarded with the Carl-von-Rotteck Preis 1992. European Award for Legal Theory 1994 and teaching at the European Academy of Legal Theory in Brussels 1994-1996. Study of Law at the University of Athens 1976-1981 and postgraduate studies in History and Theory of Institutions at the University of Sorbonne Paris II-Panthéon 1981-1983 with a scholarship of the Greek National Scholarships Foundation. Attorney-at-Law at the Athens Bar since 1983. Speak fluent Greek, German, French and English. Currently teaching Practical Philosophy, Theory of Democracy, Bioethics and Philosophy of Law.

Research projects / interests:

  • Theory of Deliberative Democracy
    (Author of the book “Deliberative Democracy and Communicational Ethics” in Greek, Athens 2005)
  • Principles of Justice: Distributive Justice in International Law
    (Author of the book: “Theorie des juristischen Diskurses. Eine institutionelle Epistemologie des Rechts”, in German, Berlin 1995)
  • Bioethical Dilemmas and Ecocentric Environmental Ethics
    (Study in preparation, about the shift of bioethical thinking from mankind-centered individual responsibility to a nature-centered model of thinking incl. non-human animals)
  • The Diffusion of Practical Philosophical Knowledge from Academia to Society
    (subject of a recently submitted research project to the Greek National Foundation of Research)

Areas of interest:

  • Polar Governance
  • Humanities
  • Antarctic Treaty System
  • Polar Policy
  • Geopolitics
  • Cultural Studies
  • Environmental Ethics
  • Values

Nikoleta Psatha

Aristotle University of Thessaloniki, Greece

Επίκουρη καθηγήτρια του Τμήματος Βιολογίας, ΣΘΕ, ΑΠΘ. Απόφοιτη της σχολής Μοριακής Βιολογίας και Γενετικής, ΔΠΘ, εκπόνησε τη διδακτορική της διατριβή στο Τμήμα Βιολογίας του ΑΠΘ σε συνεργασία με τη Μονάδα Γονιδιακής και Κυτταρικής Θεραπείας, Αιματολογική κλινική, Νοσοκομείο Γ. Παπανικολάου (2007-2014). Στη συνέχεια πραγματοποίησε μεταδιδακτορική έρευνα στο University of Washington, Seattle, USA (2014-2018), στο Altius Institute for Biomedical Sciences, Seattle, USA (2018-2021) και στο Vlaams Instituut voor Biotechnologie, Leuven, Belgium (2021). Το ερευνητικό της έργο στηρίζεται σε δύο κύριους πυλώνες: α)στη μελέτη του πολλαπλασιασμού, ανάπτυξης και διαφοροποίησης αιμοποιητικών στελεχιαίων κυττάρων και β)στην ανάπτυξη νέων μεθόδων γονιδιακής θεραπείας μέσω γονιδιακής προσθήκης ή γενετικής/επιγενετικής επεξεργασίας.